UNSPSC 51342703: Telaprevir

This classification denotes an antiviral agent with the molecular formula C36H53N7O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 655M5O3W0U. European Medicines Agency schedules telaprevir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31651. The term TELAPREVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, no. 3, 2006, list 56. ). Most nations schedule telaprevir under HS 29339990 and SITC 51577.

As of Q4 2014, TELAPREVIR remains the US FDA Preferred Term for this commodity. Telaprevir bears US NLM identifiers UMLS ID C1876229 and NCI Concept Code C81603. SMILES: CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5.

UNSPSC 51342703 Telaprevir, a Commodity code, does not align with the state and local procurement activity currently posted under this classification. The recent opportunities tagged to this code include naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas Health and Human Services Commission), medical and first aid supplies for emergency response (City of Tampa), and generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations involve telaprevir procurement specifically. The issuing bodies span county health departments, state health agencies, municipal fire departments, and regional cooperative purchasing alliances; the work being solicited is general pharmaceutical supply, medical consumables, and emergency-response inventory rather than a single-drug antiviral acquisition.

The recent opportunities show activity across Florida, Texas, Minnesota, and Oregon, but the geographic spread and issuing-body mix reflect general pharmaceutical and medical-supply procurement rather than telaprevir-specific demand. Seminole County's IFB 60459723LAS, due July 26, 2023, seeks naloxone and drug deactivation systems on a quarterly basis. The Texas Health and Human Services Commission's RFI HHS0017013, with a response deadline of April 3, 2026, explores direct-to-manufacturer prescription contracting. The City of Tampa's sealed-bid solicitation 26P00145, due March 13, 2026, targets medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 and a 5% Small Local Business Enterprise bid discount. The Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802, due March 26, 2026, covers generic multi-source pharmaceuticals and OTC products across state and local facilities. The code shows little relevant recent activity aligned specifically to telaprevir procurement.